Interactive program
Tuesday 21 March 2023
-
-
Welcome
Fabio S Taccone (Brussels, Belgium)
Jean-Louis Vincent (Brussels, Belgium)
-
-
Report of the Round Table conference: ICU populations: from syndromes to phenotypes
Carolyn S Calfee (San Francisco, United States)
Anthony Gordon (London, United Kingdom)
-
-
Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19
Ewan Goligher (Toronto, Canada)
-
-
Intravenous ravulizumab in mechanically ventilated patients hospitalized with severe COVID-19
Djillali Annane (Garches, France)
-
-
Hydrocortisone in severe community-acquired pneumonia
Nicholas Heming (Garches, France)
-
-
Early administration of prothrombin complex concentrate in trauma patients at risk of massive transfusion (PROCOAG)
Pierre Bouzat (Grenoble, France)
-
-
Tight glucose control in the absence of early parenteral nutrition
Jan Gunst (Leuven, Belgium)
-
-
Low versus standard calorie and protein feeding in ventilated adults with shock (NUTRIREA-3)
Jean Reignier (Nantes, France)
-
-
Max Harry Weil lecture: equity and equality in the ICU
Katarzyna Kotfis (Szczecin, Poland)
-
-
Hospital violence: critical care professionals at risk
Lewis J Kaplan (Philadelphia, United States)
DONATION AFTER CARDIAC DEATH
Paul H Mayo (New York, United States)
-
-
How to make it possible?
Marlies Ostermann (London, United Kingdom)
-
-
How ECMO can facilitate it
Rafael Badenes (Valencia, Spain)
-
-
How we do it
Jan Belohlavek (Prague, Czech Republic)
-
-
How we can improve it
Jacques Creteur (Brussels, Belgium)
-
-
Discussion
COVID-19: WHAT WE LEARNED
V Marco Ranieri (Bologna, Italy)
-
-
Immune profiling could identify severity
Nuala Meyer (Philadelphia, United States)
-
-
A better understanding of immunomodulation
Lieuwe Bos (Amsterdam, Netherlands)
-
-
The different responses to convalescent plasma therapy
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Discussion
-
-
It was different in children?
Adrienne Randolph (Boston, United States)
-
-
About the heterogeneity of myocarditis
Alain Combes (Paris, France)
-
-
How the epidemiology of bacterial infections has been affected
Matteo Bassetti (Genoa, Italy)
-
-
Discussion
-
-
About antivirals
Joost Wiersinga (Amsterdam, Netherlands)
-
-
About other ICU treatments
Anthony Gordon (London, United Kingdom)
-
-
Anti-C5a antibody was the best
Alexander Vlaar (Amsterdam, Netherlands)
-
-
Inhaled heparin as an option
Frank van Haren (Sidney, Australia)
-
-
Discussion
-
-
About stress, anxiety and burnout among the health care team
Michelle Chew (Linköping, Sweden)
-
-
About living guidelines
Janet Diaz (Geneva, Switzerland)
-
-
Is there still something to learn?
Tobias Welte (Hannover, Germany)
-
-
Discussion
SUBARACHNOID HEMORRHAGE
David Menon (Cambridge, United Kingdom)
-
-
Critical care management
Soojin Park (New York, United States)
-
-
A role for other medical therapies?
Georgia Tsaousi (Thessaloniki, Greece)
-
-
Can ROTEM help to predict cerebral ischemia?
Nicole Juffermans (Amsterdam, Netherlands)
-
-
Delayed cerebral ischemia: still a role for induced hypertension?
Walter van den Bergh (Groningen, Netherlands)
-
-
Discussion
-
-
Catheter-associated bloodstream infections
Philippe Eggimann (Lausanne, Switzerland)
-
-
Probiotics may decrease the risk of lung infection
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
-
Advanced airway devices to reduce risk of VAP
Paul Dark (Manchester, United Kingdom)
-
-
Other new approaches to VAP prevention
Philippe Montravers (Paris, France)
-
-
Discussion
-
-
SDD - here we go again?
Jan De Waele (Ghent, Belgium)
-
-
Why aren´t you using SDD?
Simon Finfer (Newtown, Australia)
-
-
Indications for antibiotic prophylaxis
Pedro Povoa (Lisbon, Portugal)
-
-
Discussion
-
-
Break
TRAUMATIC BRAIN INJURY
Soojin Park (New York, United States)
-
-
A very heterogeneous entity!
Marek Mirski (Baltimore, United States)
-
-
Different in pregnant patients?
Chiara Robba (Genoa, Italy)
-
-
How has outcome improved?
David Menon (Cambridge, United Kingdom)
-
-
Extreme therapies
Giuseppe Citerio (Monza, Italy)
-
-
Discussion
INTRACRANIAL HYPERTENSION
Chiara Robba (Genoa, Italy)
-
-
Current indications for ICP monitoring
Giuseppe Citerio (Monza, Italy)
-
-
Benefits and risks of hyperosmolar therapy
Marek Mirski (Baltimore, United States)
-
-
Is hypertonic lactate the solution?
Mauro Oddo (Lausanne, Switzerland)
-
-
Is hypertonic saline the solution?
Georgia Tsaousi (Thessaloniki, Greece)
-
-
Discussion
NEUROMONITORING
Mauro Oddo (Lausanne, Switzerland)
-
-
Pupil reactivity: the simplest method
Giuseppe Citerio (Monza, Italy)
-
-
Biomarkers
David Menon (Cambridge, United Kingdom)
-
-
Brain tissue oxygenation
Pierre Bouzat (Grenoble, France)
-
-
Discussion
-
-
Brain metabolic monitoring
Raimund Helbok (Linz, Austria)
-
-
Multimodal brain monitoring: EEG + Doppler + NIRS
André Denault (Montreal, Canada)
-
-
How I integrate it all
Geert Meyfroidt (Leuven, Belgium)
-
-
It´s not only a matter of thresholds
Soojin Park (New York, United States)
-
-
Discussion
-
-
Clinical trials in COVID:
PRO: John C Marshall (Toronto, Canada)
CON: Mervyn Singer (London, United Kingdom)
LIFE AFTER INTENSIVE CARE
Peter Pickkers (Nijmegen, Netherlands)
-
-
Quality of life after cardiac arrest
Claudio Sandroni (Rome, Italy)
-
-
Frailty and persistent critical illness
Rinaldo Bellomo (Melbourne, Australia)
-
-
Altered DNA methylation drives PICS
Greet Van den Berghe (Leuven, Belgium)
-
-
What happens to the cirrhotic patient?
Thierry Gustot (Brussels, Belgium)
-
-
Discussion
SHEDDING LIGHT ON ARDS
B Taylor Thompson (Boston, United States)
-
-
ARDS in immunocompromised patients is a specific entity
Alexandre Demoule (Paris, France)
-
-
Pediatric ARDS is also different
Adrienne Randolph (Boston, United States)
-
-
Respiratory subsets: my personal view
Jesus Villar (Las Palmas de Gran Canaria, Spain)
-
-
Discussion
-
-
ARDS subphenotypes: lessons from COVID-19
Lieuwe Bos (Amsterdam, Netherlands)
-
-
Phenotypes are moving closer to clinical trials
Carolyn S Calfee (San Francisco, United States)
-
-
Studying the lung microbiome can help
Massimo Antonelli (Rome, Italy)
-
-
Discussion
-
-
Break
-
-
Corticosteroid administration in ARDS
CON: B Taylor Thompson (Boston, United States)
PRO: Jesus Villar (Las Palmas de Gran Canaria, Spain)
CELLULAR HOMEOSTASIS
Edward Schenck (New York, United States)
-
-
Mitochondrial dysfunction
Arthur van Zanten (Ede, Netherlands)
-
-
Biogenesis
Tim Rahmel (Bochum, Germany)
-
-
Metabolomics
Carolyn S Calfee (San Francisco, United States)
-
-
Lipidomics
Tom van der Poll (Amsterdam, Netherlands)
-
-
Microcirculation
Matthias Hilty (Zurich, Switzerland)
-
-
Discussion
FUTURE SEPSIS THERAPIES
Bruno François (Limoges, France)
-
-
Focus on disease tolerance in sepsis
Christopher Seymour (Pittsburgh, United States)
-
-
More immunoglobulin administration?
Tobias Welte (Hannover, Germany)
-
-
Immune stimulation
Anthony Gordon (London, United Kingdom)
-
-
Discussion
-
-
Extracorporeal immune cell therapy for immune stimulation
Steffen R. Mitzner (Rostock, Germany)
-
-
Checkpoint inhibitors
David Grimaldi (Brussels, Belgium)
-
-
TREM-1 inhibition in septic shock
Sébastien Gibot (Nancy, France)
-
-
Discussion
-
-
Recombinant alkaline phosphatase for renal protection
Peter Pickkers (Nijmegen, Netherlands)
-
-
Targeting coagulation
Julie Helms (Strasbourg, France)
-
-
We will personalize therapies
Lennie Derde (Utrecht, Netherlands)
-
-
Discussion
FLUID RESUSCITATION AND REMOVAL
Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
-
-
Does the concept of liberal vs. restrictive fluid administration make sense?
Nathan Shapiro (Boston, United States)
-
-
The limitations of fluid responsiveness tests
Sheila N Myatra (Mumbai, India)
-
-
Look only at the peripheral perfusion
Jan Bakker (New York, United States)
-
-
Look only at the microcirculation
Jacques Duranteau (Le Kremlin-Bicêtre, France)
-
-
Look at the patient, not at the fluid balance
Daniel De Backer (Braine l´Alleud, Belgium)
-
-
Discussion
FLUID DEESCALATION
Michelle Chew (Linköping, Sweden)
-
-
How I reduce fluid overload
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
Fluid deescalation: when and how?
Daniel De Backer (Braine l´Alleud, Belgium)
-
-
It may cause harm
Can Ince (Rotterdam, Netherlands)
-
-
Use of miniaturized systems to remove fluid
Claudio Ronco (Vicenza, Italy)
-
-
Discussion
NUTRITIONAL SUPPORT
Stéphane Gaudry (Bobigny, France)
-
-
Enteral nutrition: my 10 recommendations
Annika Reintam Blaser (Tartu, Estonia)
-
-
More calories?
Adam Deane (Victoria, Australia)
-
-
More amino acids?
Nicholas Heming (Garches, France)
-
-
More micronutrients?
Angelique de Man (Amsterdam, Netherlands)
-
-
Discussion
-
-
Bioimpedance may guide protein dosing
Arthur van Zanten (Ede, Netherlands)
-
-
How the type of food can influence the acute illness
Lioudmila Karnatovskaia (Rochester, United States)
-
-
Blood glucose targets in critically ill patients
Jan Gunst (Leuven, Belgium)
-
-
Glucose control in diabetic patients
Adam Deane (Victoria, Australia)
-
-
Discussion
-
-
Break
HOW TO USE RESOURCES WISELY
Edward Schenck (New York, United States)
-
-
ICU admission after major surgery: is there a survival benefit?
Diamanto Aretha (Patras, Greece)
-
-
Influence of national income on ICU structure and organization
Armand Mekontso Dessap (Créteil, France)
-
-
When even the oxygen supply becomes limited
Janet Diaz (Geneva, Switzerland)
-
-
Discussion
-
-
The frugal intensivist: peripheral i.v. vasopressor use and no arterial line
Paul H Mayo (New York, United States)
-
-
There are simple ways to measure blood pressure correctly
Bernd Saugel (Hamburg, Germany)
-
-
Whatshould we do in the absence of hemodynamic monitoring devices?
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
Discussion
-
-
The Swiss Personalized Health Network for sepsis
Thierry Calandra (Lausanne, Switzerland)
-
-
The French sepsis database
Djillali Annane (Garches, France)
-
-
The Amsterdam critical care database
Nicole Juffermans (Amsterdam, Netherlands)
-
-
Discussion
-
-
The Michigan data driven quality improvement
Hallie Prescott (Ann Arbor, United States)
-
-
The Australasian experience
Simon Finfer (Newtown, Australia)
-
-
What can we do with all this data?
Edward Schenck (New York, United States)
-
-
Discussion
NUTRITIONAL MANAGEMENT
Simon Finfer (Newtown, Australia)
-
-
Early starvation may be desirable
Jan Gunst (Leuven, Belgium)
-
-
What happens after ICU discharge?
Elisabeth De Waele (Brussels, Belgium)
-
-
Should the ICU team control post-ICU nutrition?
Arthur van Zanten (Ede, Netherlands)
-
-
How to increase awareness of all caregivers
Jean-Charles Preiser (Brussels, Belgium)
-
-
Discussion
-
-
Pulse oximetry revisited
Tomoko Fujii (Tokyo, Japan)
-
-
PEEP titration: a practical guide
Ewan Goligher (Toronto, Canada)
-
-
Management of cardiogenic shock
Hannah Schaubroeck (Ghent, Belgium)
-
-
Venous return: physiology and applications
Antoine Vieillard–Baron (Boulogne-Billancourt, France)
-
-
Cardiorespiratory failure in liver disease
Julia Wendon (London, United Kingdom)
-
-
COVID-19: a review of pharmacologic management
Craig M Coopersmith (Atlanta, United States)
-
-
Non-invasive respiratory support: what to choose?
Massimo Antonelli (Rome, Italy)
Alexandre Demoule (Paris, France)
Gavin Perkins (Warwick, United Kingdom)
Lise Piquilloud (Lausanne, Switzerland)
-
-
Pancreatitis
Angelique de Man (Amsterdam, Netherlands)
Philippe Montravers (Paris, France)
-
-
ECMO for refractory respiratory failure
Daniel Brodie (Baltimore, United States)
Giacomo Grasselli (Milan, Italy)
-
-
Which monitoring do you need for this patient?
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
VA ECMO
Federico Pappalardo (Alessandria, Italy)
Alexander Vlaar (Amsterdam, Netherlands)
-
-
Challenging airways
Audrey De Jong (Montpellier, France)
Sheila N Myatra (Mumbai, India)
-
-
Patient-ventilator asynchronies
Leo Heunks (Rotterdam, Netherlands)
Katerina Vaporidi (Heraklion, Greece)
-
-
Palliative care in the ICU
Jacques Creteur (Brussels, Belgium)
Victoria Metaxa (London, United Kingdom)
-
-
Assessing arterial tone at the bedside
Michael R Pinsky (Pittsburgh, United States)
Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
-
-
Identifying dyssynchrony
Elias N Baedorf Kassis (Boston, United States)
Daniel Talmor (Boston, United States)
-
-
Refractory septic shock
Alain Combes (Paris, France)
Hayley B Gershengorn (Miami, United States)
-
-
How I optimize power at the bedside to avoid VILI
Luciano Gattinoni (Göttingen, Germany)
John J Marini (St Paul, United States)
-
-
Acquired diaphragm dysfunction
Alexandre Demoule (Paris, France)
Ewan Goligher (Toronto, Canada)
-
-
The frail neurological patient
Raimund Helbok (Linz, Austria)
Fabio S Taccone (Brussels, Belgium)
-
-
How I use echocardiography in shock
Paul H Mayo (New York, United States)
Anthony McLean (Sydney, Australia)
Wednesday 22 March 2023
COVID-19: WHAT ALSO APPLIES TO BACTERIAL SEPSIS
Matteo Bassetti (Genoa, Italy)
-
-
What COVID-19 taught us about sepsis
John C Marshall (Toronto, Canada)
-
-
How different from bacterial sepsis?
Djillali Annane (Garches, France)
-
-
Were the thrombocoagulopathic mechanisms different?
Beverley Hunt (London, United Kingdom)
-
-
Discussion
-
-
Were anticoagulation strategies different?
Armand Mekontso Dessap (Créteil, France)
-
-
The role of platelets was interesting
Tom van der Poll (Amsterdam, Netherlands)
-
-
The metabolic response was quite different
Elisabeth De Waele (Brussels, Belgium)
-
-
Discussion
-
-
Was the response of the microcirculation different?
Can Ince (Rotterdam, Netherlands)
-
-
Was the risk of VAP particularly high?
Pedro Povoa (Lisbon, Portugal)
-
-
We could be skeptical about corticosteroids
Daniel Talmor (Boston, United States)
-
-
Discussion
-
-
Anti-TREM-1 approaches are promising
Bruno François (Limoges, France)
-
-
Were secondary infections different?
Jan De Waele (Ghent, Belgium)
-
-
Was the post-COVID syndrome different from PICS?
Carol Hodgson (Melbourne, Australia)
-
-
Discussion
SHEDDING LIGHT ON SEPSIS
Anthony Gordon (London, United Kingdom)
-
-
Metagenomic sequencing in the ICU
Carolyn S Calfee (San Francisco, United States)
-
-
Is sepsis very different in children?
Adrienne Randolph (Boston, United States)
-
-
Adaptive immune system responses during critical illness: all the same?
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Subphenotyping based on organ dysfunction trajectory in sepsis
Edward Schenck (New York, United States)
-
-
Let´s individualize corticosteroid administration
Djillali Annane (Garches, France)
-
-
Discussion
PERSONALIZING THE CHOICE OF IV FLUID
Nathan Shapiro (Boston, United States)
-
-
Saline solutions are not bad: hyperchloremia is
Jean-Louis Vincent (Brussels, Belgium)
-
-
Chloride is a neglected electrolyte
Luciano Gattinoni (Göttingen, Germany)
-
-
What´s in a bag of fluid? Tailoring the fluid to the patient
Mervyn Singer (London, United Kingdom)
-
-
When to give bicarbonate in metabolic acidosis
Tomoko Fujii (Tokyo, Japan)
-
-
Discussion
-
-
Appropriate choices in sepsis
Ricard Ferrer (Barcelona, Spain)
-
-
Why not plasma in sepsis?
Christopher Seymour (Pittsburgh, United States)
-
-
Appropriate choices in neurological disease
Marek Mirski (Baltimore, United States)
-
-
Appropriate choices in liver disease
Julia Wendon (London, United Kingdom)
-
-
Discussion
HEMODYNAMIC MANAGEMENT OF THE NEUROLOGICAL PATIENT
Chiara Robba (Genoa, Italy)
-
-
Ultrasound to study cerebral hemodynamics
Aarti Sarwal (Winston Salem, United States)
-
-
Induced hypertension when needed
Fabio S Taccone (Brussels, Belgium)
-
-
Don´t forget cardiac output!
Geert Meyfroidt (Leuven, Belgium)
-
-
Using cardiac signals can also help
Soojin Park (New York, United States)
-
-
Discussion
ARE OUR SYNDROMES STILL USEFUL?
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Is it time to abandon consensus definitions of ARDS and sepsis?
Gordon Rubenfeld (Toronto, Canada)
-
-
If a better ARDS definition is the answer, what is the question?
V Marco Ranieri (Bologna, Italy)
-
-
We need to expand the ARDS criteria
Oriol Roca (Sabadell, Spain)
-
-
Sepsis subtypes
Christopher Seymour (Pittsburgh, United States)
-
-
Discussion
-
-
Bridging the gap for precision medicine
B Taylor Thompson (Boston, United States)
-
-
Finding the treatable traits in ARDS and sepsis
Nuala Meyer (Philadelphia, United States)
-
-
Let us (re)define critical illness
John C Marshall (Toronto, Canada)
-
-
Let us better define clinical trajectories
Michelle N Gong (New York, United States)
-
-
Discussion
CLINICAL TRIALS
Hallie Prescott (Ann Arbor, United States)
-
-
Many practices are not based on a sound evidence base
Mervyn Singer (London, United Kingdom)
-
-
Problems of randomized controlled trials in ARDS
Jesus Villar (Las Palmas de Gran Canaria, Spain)
-
-
Problems with mortality as an endpoint
Michelle N Gong (New York, United States)
-
-
Novel trial designs should include phenotypes
Christopher Seymour (Pittsburgh, United States)
-
-
Discussion
-
-
ICU trials should be Bayesian
Ewan Goligher (Toronto, Canada)
-
-
Adaptive platform trials for all
Carolyn S Calfee (San Francisco, United States)
-
-
We could consider basket trials
B Taylor Thompson (Boston, United States)
-
-
Discussion
-
-
Global collaboration is the future
John C Marshall (Toronto, Canada)
-
-
Using observational cohort studies to complement clinical trials
Nuala Meyer (Philadelphia, United States)
-
-
Redesigning ICU research: more data science, fewer interventional trials
Mauro Oddo (Lausanne, Switzerland)
-
-
Discussion
-
-
ARDS: time to abandon?
PRO: Luciano Gattinoni (Göttingen, Germany)
CON: Michelle N Gong (New York, United States)
VV ECMO: WHAT WE´VE LEARNED RECENTLY
Luciano Gattinoni (Göttingen, Germany)
-
-
Obesity is not a contraindication
Daniel Brodie (Baltimore, United States)
-
-
Age limits revisited
V Marco Ranieri (Bologna, Italy)
-
-
Consider RV function as well
Antoine Vieillard–Baron (Boulogne-Billancourt, France)
-
-
Discussion
-
-
How we used ECMO for severe COVID-19
Alain Combes (Paris, France)
-
-
There was an interesting evolution in the use of ECMO during COVID-19
Daniel Brodie (Baltimore, United States)
-
-
How ECMO changed outcome during COVID-19
Luigi Camporota (London, United Kingdom)
-
-
ECMO: let´s challenge our current practices
Carol Hodgson (Melbourne, Australia)
-
-
Discussion
-
-
Break
-
-
We should abandon CVP monitoring
PRO: Paul H Mayo (New York, United States)
CON: Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
-
-
We should abandon pragmatic trials
CON: Rinaldo Bellomo (Melbourne, Australia)
PRO: Jean-Louis Vincent (Brussels, Belgium)
DIFFICULT INFECTIONS
Tobias Welte (Hannover, Germany)
-
-
First distinguish bacterial from viral infection
Pierre Hausfater (Paris, France)
-
-
S. aureus infections in the ICU
Sebastian Weis (Jena, Germany)
-
-
Klebsiella is the new threat
Matteo Bassetti (Genoa, Italy)
-
-
Risk stratification of multidrug resistant bacteria
Philippe Montravers (Paris, France)
-
-
What is the real threat from antibiotic resistance?
Liesbet De Bus (Ghent, Belgium)
-
-
Discussion
-
-
Any place for phage therapy?
Maya Hites (Brussels, Belgium)
-
-
How to work closely with the Infectious Disease specialist
Sebastian Weis (Jena, Germany)
-
-
CMV in immunocompetent ICU patients: prevent, treat, or ignore
Gordon Rubenfeld (Toronto, Canada)
-
-
Novel antifungal agents
Thierry Calandra (Lausanne, Switzerland)
-
-
Candida resistance and antifungal stewardship
José-Artur Paiva (Porto, Portugal)
-
-
Discussion
-
-
Vitamins and trace-elements: invisible but vital!
Elisabeth De Waele (Brussels, Belgium)
-
-
The cardiovascular effects of vitamin C
Angelique de Man (Amsterdam, Netherlands)
-
-
Mega-dose vitamin C?
Rinaldo Bellomo (Melbourne, Australia)
-
-
Discussion
-
-
Vitamin B in hypophosphatemia?
Adam Deane (Victoria, Australia)
-
-
Vitamin B3 for renal protection?
Stéphane Gaudry (Bobigny, France)
-
-
When to give vitamin D?
Jean-Charles Preiser (Brussels, Belgium)
-
-
Vitamin D in renal failure?
Marlies Ostermann (London, United Kingdom)
-
-
Discussion
-
-
Break
-
-
Hypophosphatemia should be corrected
PRO: Jean-Charles Preiser (Brussels, Belgium)
CON: Mervyn Singer (London, United Kingdom)
WE SHOULD MONITOR THE MICROCIRCULATION IN THE PERIOPERATIVE PERIOD
-
-
We should monitor the microcirculation in the perioperative period
PRO: Jacques Duranteau (Le Kremlin-Bicêtre, France)
CON: Bernd Saugel (Hamburg, Germany)
-
-
The danger within our body
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
-
Necroinflammatory cell death in sepsis
Edward Schenck (New York, United States)
-
-
Endotoxin has a hormone-like effect
John C Marshall (Toronto, Canada)
-
-
Discussion
-
-
Host response aberrations in ICU-acquired pneumonia
Tom van der Poll (Amsterdam, Netherlands)
-
-
Myeloid-derived suppressor cells as mediators of immunosuppression
Thierry Calandra (Lausanne, Switzerland)
-
-
The role of mitochondria in the immune response
Anthony McLean (Sydney, Australia)
-
-
Discussion
-
-
Compartmentalization of immune responses
Manu Shankar–Hari (Edinburgh, United Kingdom)
-
-
Sustained inflammation can be associated with mortality
Lieuwe Bos (Amsterdam, Netherlands)
-
-
Disease tolerance as an important concept
Sebastian Weis (Jena, Germany)
-
-
Treating fever? … or normothermia?
Mervyn Singer (London, United Kingdom)
-
-
Discussion
-
-
Intoxications
Heatherlee Bailey (Durham, United States)
-
-
Measure creatinine more frequently
Rinaldo Bellomo (Melbourne, Australia)
-
-
Kidney responses to novel therapeutic strategies
Can Ince (Rotterdam, Netherlands)
-
-
Role of identifying subphenotypes
Marlies Ostermann (London, United Kingdom)
-
-
Management in patients with cirrhosis
Thierry Gustot (Brussels, Belgium)
-
-
Discussion
-
-
The optimal blood pressure for the kidneys
Frank van Haren (Sidney, Australia)
-
-
The best vasopressor for the kidney?
Jacques Duranteau (Le Kremlin-Bicêtre, France)
-
-
Vasopressin could have renal protective effects
Patrick Honoré (Yvoir, Belgium)
-
-
Bicarbonate administration: good or bad?
Lui Forni (Guildford, United Kingdom)
-
-
Discussion
-
-
Ventilator dyssynchrony
Elias N Baedorf Kassis (Boston, United States)
-
-
Drug toxicity in cancer patients
Stephen M Pastores (New York, United States)
-
-
Acute exacerbation of chronic respiratory disease
Tobias Welte (Hannover, Germany)
-
-
Physiological principles
Matthias Hilty (Zurich, Switzerland)
-
-
Selecting the right patients
Ewan Goligher (Toronto, Canada)
-
-
For moderate to severe ARDS
Alain Combes (Paris, France)
-
-
Combination with CRRT in ARDS
V Marco Ranieri (Bologna, Italy)
-
-
Is ECCO2R also good for oxygenation?
Luciano Gattinoni (Göttingen, Germany)
-
-
Discussion
-
-
Break
-
-
Thrombocytopenia in the ICU
Elie Azoulay (Paris, France)
-
-
When to suspect a thrombotic microangiopathy
Achim Jörres (Cologne, Germany)
-
-
Emerging treatment options
Sascha David (Zurich, Switzerland)
-
-
Discussion
-
-
Liver-induced coagulopathies
Julia Wendon (London, United Kingdom)
-
-
Sepsis-induced coagulopathy
Julie Helms (Strasbourg, France)
-
-
Should we give iron to the critically ill?
Nicole Juffermans (Amsterdam, Netherlands)
-
-
A research agenda for hemoncology patients
Elie Azoulay (Paris, France)
-
-
Discussion
ARTIFICIAL INTELLIGENCE IN THE ICU
Marek Mirski (Baltimore, United States)
-
-
The future is bright
Vincent Liu (Oakland, United States)
-
-
… but artificial intelligence has a dark side
Jan De Waele (Ghent, Belgium)
-
-
… and it´s not smart if it doesn´t improve outcomes
Michelle N Gong (New York, United States)
-
-
Discussion
-
-
Machine learning can identify subphenotypes
Edward Schenck (New York, United States)
-
-
How AI can prevent hemodynamic crises
Alexander Vlaar (Amsterdam, Netherlands)
-
-
How it may improve hemodynamic management
Michael R Pinsky (Pittsburgh, United States)
-
-
Discussion
-
-
How it can analyze microcirculatory alterations
Matthias Hilty (Zurich, Switzerland)
-
-
How it may predict cerebral complications
Soojin Park (New York, United States)
-
-
How it may predict coma recovery
Mauro Oddo (Lausanne, Switzerland)
-
-
Developing further prediction models
Vincent Liu (Oakland, United States)
-
-
Discussion
-
-
Coagulopathies
Julie Helms (Strasbourg, France)
WEANING FROM MECHANICAL VENTILATION
Armand Mekontso Dessap (Créteil, France)
-
-
What is complicated weaning?
Lise Piquilloud (Lausanne, Switzerland)
-
-
How to assess muscle strength
Alexandre Demoule (Paris, France)
-
-
When, where and how to extubate?
Audrey De Jong (Montpellier, France)
-
-
Discussion
-
-
Non-traditional risk factors for failed extubation
Hayley B Gershengorn (Miami, United States)
-
-
How to optimize weaning in children
Adrienne Randolph (Boston, United States)
-
-
Extubation failure in neurological patient
Chiara Robba (Genoa, Italy)
-
-
Non-invasive ventilation to support the weaning process
Gavin Perkins (Warwick, United Kingdom)
-
-
Discussion
-
-
ECMO: things to remember
Leen Vercaemst (Leuven, Belgium)
IMPROVING VASOPRESSOR USE
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
When is the radial artery pressure unreliable?
André Denault (Montreal, Canada)
-
-
The peripheral i.v. route is acceptable
Hallie Prescott (Ann Arbor, United States)
-
-
Norepinephrine infusion should be started early
Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
-
-
How to promote veno-constriction
Daniel De Backer (Braine l´Alleud, Belgium)
-
-
Discussion
-
-
Starting with vasopressin?
Diamanto Aretha (Patras, Greece)
-
-
New vasopressors, new evidence
Ashish K Khanna (Winston-Salem, United States)
-
-
Angiotensin II has additional properties
Rinaldo Bellomo (Melbourne, Australia)
-
-
Discussion
-
-
The vasopressor test
Jan Bakker (New York, United States)
-
-
Combination therapies in septic shock: when and how?
Sharon Einav (Jerusalem, Israel)
-
-
When to add an inotropic agent?
Michelle Chew (Linköping, Sweden)
-
-
Discussion
-
-
… or a beta blocker?
Vasileios Papaioannou (Alexandroupolis, Greece)
-
-
Continuing controversies
Hannah Wunsch (Toronto, Canada)
-
-
What do we mean by ´refractory` septic shock?
Ricard Ferrer (Barcelona, Spain)
-
-
Discussion
-
-
Cardiac arrest guidelines
Gavin Perkins (Warwick, United Kingdom)
RENAL REPLACEMENT THERAPY
Steffen R. Mitzner (Rostock, Germany)
-
-
Diffusion, convection, adsorption: what´s best?
Claudio Ronco (Vicenza, Italy)
-
-
Can we predict who will need RRT?
Lui Forni (Guildford, United Kingdom)
-
-
How the choice may influence recovery
Rinaldo Bellomo (Melbourne, Australia)
-
-
Discussion
-
-
CVVHD is so much better than CVVH
Xose L Pérez Fernández (Bueu, Spain)
-
-
How to effectively prolong CRRT filter life
Tomoko Fujii (Tokyo, Japan)
-
-
Regional citrate anticoagulation
Joop Jonckheer (Brussels, Belgium)
-
-
How to reduce the risk of RRT-induced kidney injury
Stéphane Gaudry (Bobigny, France)
-
-
Discussion
-
-
Optimal fluid management
Marlies Ostermann (London, United Kingdom)
-
-
Optimal feeding
Joop Jonckheer (Brussels, Belgium)
-
-
When to stop
Achim Jörres (Cologne, Germany)
-
-
The remaining questions
Dmytro Khadzhynov (Berlin, Germany)
-
-
Discussion
-
-
New antibiotics
Tobias Welte (Hannover, Germany)
-
-
How to talk to the media about scientific findings
Craig M Coopersmith (Atlanta, United States)
-
-
Antimicrobial stewardship
Paul Dark (Manchester, United Kingdom)
Jan De Waele (Ghent, Belgium)
Lennie Derde (Utrecht, Netherlands)
José-Artur Paiva (Porto, Portugal)
-
-
Macrophage activation syndrome
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
-
ECPR: when, where, how and for whom?
Jan Belohlavek (Prague, Czech Republic)
Daniel De Backer (Braine l´Alleud, Belgium)
Claudio Sandroni (Rome, Italy)
Leen Vercaemst (Leuven, Belgium)
-
-
How to cope with ICU burnout?
Daniel Brodie (Baltimore, United States)
Sheila N Myatra (Mumbai, India)
Stephen M Pastores (New York, United States)
Fabio S Taccone (Brussels, Belgium)
-
-
Dyspnea in mechanically ventilated patients
Alexandre Demoule (Paris, France)
-
-
Coma
Raimund Helbok (Linz, Austria)
-
-
Hemodynamic monitoring techniques
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
-
Advanced respiratory monitoring
Lise Piquilloud (Lausanne, Switzerland)
-
-
What temperature after cardiac arrest?
Jerry Nolan (Bath, United Kingdom)
Chiara Robba (Genoa, Italy)
Claudio Sandroni (Rome, Italy)
Markus Skrifvars (Helsinki, Finland)
-
-
A case of diarrhea
Annika Reintam Blaser (Tartu, Estonia)
-
-
Advancing sedation strategies
Michael Reade (Brisbane, Australia)
Yahya Shehabi (Clayton, Australia)
-
-
Non-invasive ventilatory support
Massimo Antonelli (Rome, Italy)
Lise Piquilloud (Lausanne, Switzerland)
-
-
Blood purification techniques
Gabriella Bottari (Rome, Italy)
Claudio Ronco (Vicenza, Italy)
-
-
Monitoring respiratory mechanics, drive, and effort
Giacomo Grasselli (Milan, Italy)
Leo Heunks (Rotterdam, Netherlands)
-
-
CAR-T toxicity
Victoria Metaxa (London, United Kingdom)
-
-
Management of thoracic trauma
Jacques Duranteau (Le Kremlin-Bicêtre, France)
Marc Maegele (Cologne, Germany)
-
-
Non-resolving conflicts with relatives
Elie Azoulay (Paris, France)
Victoria Metaxa (London, United Kingdom)
-
-
Refeeding syndrome
Annika Reintam Blaser (Tartu, Estonia)
Arthur van Zanten (Ede, Netherlands)
-
-
Transesophageal lung ultrasonography
Daniel De Backer (Braine l´Alleud, Belgium)
Paul H Mayo (New York, United States)
-
-
Lung recruitment
Laurent Brochard (Toronto, Canada)
John J Marini (St Paul, United States)
-
-
Coagulopathy: differential diagnosis
Elie Azoulay (Paris, France)
-
-
Antibiotic prophylaxis in patients colonized with MDR bacteria
Philippe Montravers (Paris, France)
Pedro Povoa (Lisbon, Portugal)
-
-
Massive bleeding
Nicole Juffermans (Amsterdam, Netherlands)
Marc Maegele (Cologne, Germany)
-
-
Critical care echocardiography
Anthony McLean (Sydney, Australia)
Susanna Price (London, United Kingdom)
-
-
Vasopressor management in septic shock
Arthur van Zanten (Ede, Netherlands)
-
-
Advanced hemodynamic monitoring in the ICU
Alexander Vlaar (Amsterdam, Netherlands)
-
-
How to use TTM after cardiac arrest?
Rinaldo Bellomo (Melbourne, Australia)
Jerry Nolan (Bath, United Kingdom)
-
-
Are you awake? Are you conscious?
Jan Claassen (New York, United States)
Jacques Duranteau (Le Kremlin-Bicêtre, France)
-
-
Analgesia and sedation strategies for neurological patients
Pierre Bouzat (Grenoble, France)
Marek Mirski (Baltimore, United States)
-
-
The patient who bleeds but needs anticoagulants
Julie Helms (Strasbourg, France)
Beverley Hunt (London, United Kingdom)
-
-
Interstitial lung diseases
Angelique de Man (Amsterdam, Netherlands)
Janet Diaz (Geneva, Switzerland)
Thursday 23 March 2023
PANDEMICS: THE BIG PICTURE
Yahya Shehabi (Clayton, Australia)
-
-
From polio to COVID-19
Hannah Wunsch (Toronto, Canada)
-
-
What infectious diseases are emerging?
Janet Diaz (Geneva, Switzerland)
-
-
How research reshaped practice
Djillali Annane (Garches, France)
-
-
Discussion
-
-
There is a need for ´frugal innovation`
Armand Mekontso Dessap (Créteil, France)
-
-
How social media broke science
Gordon Rubenfeld (Toronto, Canada)
-
-
Anticipating the next pandemic: resilience is the key
Lennie Derde (Utrecht, Netherlands)
-
-
Discussion
-
-
POSTER AWARDS